Aldevron recently announced its upcoming virtual ribbon cutting event, which will take place on Wednesday, February 10 at 12:00 PM CST. Its focus will be the company's investments in key areas, expanding Aldevron's ability to enable clients' breakthroughs in the emerging field of genetic medicine, further impacting patients and achieving the company's mission.
In the news: GEN Magazine - Plasmid Manufacturer Scales Up Production Capacity to Serve New Therapeutics
A plasmid DNA manufacturer is planning to scale up its production capacity to meet the growing needs of gene therapy. Aldevron, a company based in North Dakota, expects to open a new 189,000 sq. ft facility in spring 2021 to add to their existing 70,000 sq. ft of manufacturing space.
In June of 2019, Aldevron announced its massive 14-acre campus expansion. The construction began with a groundbreaking ceremony in August of 2019, launching the buildout of the campus’ second GMP manufacturing facility. This 189,000 square-foot, two-story building is slated to increase Aldevron’s GMP and GMP-Source production capacity up to 10 times its current output. In December of 2019, a major milestone was reached when structural steel beams were installed (pictured).
News report courtesy Forum Communication, written by Barry Amundson. Published August 29, 2019
Tax incentive supporters are putting the pressure on to show that programs being offered to businesses and developers are not only going to eventually provide impressive property tax payments but also provide positive ripple effects in the community.
Fargo, N.D., based company increasing capacity to better serve
rapidly growing biotech industry
Aldevron officially broke ground on its 14-acre campus expansion at its global headquarters in Fargo, North Dakota, August 19. Three buildings are planned, with construction of its next GMP manufacturing facility starting first.
Tom Foti, Vice President and General Manager of Aldevron's Madison site, discussed the addition of a 1,000 liter fermentor and significant expansion of the site's manufacturing space at the American Society of Gene & Cell Therapy conference in Washington, DC.
Aldevron announced today its new fermentation capacity of 1,000 liters and plans to significantly increase the Company’s manufacturing footprint in Madison, WI. The large-scale fermentation equipment is already installed and will be coming on-line in Q4 2019.
SAN DIEGO -- Aldevron announced today from the floor of the Festival of Biologics in San Diego, its expansion plans for its Freiburg, Germany facility. The Freiburg location houses the GENOVAC antibody development platform and became the second site for Aldevron in 2004.